Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

BUY
$0.3 - $306.0 $56,118 - $57.2 Million
187,060 New
187,060 $0
Q3 2021

Nov 10, 2021

SELL
$1.66 - $2.27 $113,178 - $154,768
-68,180 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$1.68 - $2.79 $7,366 - $12,234
4,385 Added 6.87%
68,180 $156,000
Q1 2021

May 14, 2021

BUY
$2.14 - $6.18 $136,521 - $394,253
63,795 New
63,795 $156,000

Others Institutions Holding WINT

About WINDTREE THERAPEUTICS INC


  • Ticker WINT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,627,900
  • Market Cap $34M
  • Description
  • Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...
More about WINT
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.